Literature DB >> 11859142

Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation.

Ellen F Foxman1, Meifen Zhang, Stephen D Hurst, Tony Muchamuel, Defen Shen, Eric F Wawrousek, Chi-Chao Chan, Igal Gery.   

Abstract

Ocular inflammation leads to vision loss through the destruction and scarring of delicate tissues along the visual axis. To identify inflammatory mediators involved in this process, we used real time RT-PCR to quantify the expression of mRNA transcripts of 34 cytokines, 26 chemokines, and 14 chemokine receptors at certain time points during T cell-mediated ocular inflammation. We induced disease by adoptive transfer of Ag-specific Th1 or Th2 cells into recipients expressing the target Ag in their eyes. We also compared the mediator expression patterns seen in adoptive transfer-induced inflammation with that seen in mouse eyes developing experimental autoimmune uveoretinitis. In addition, we used laser capture microdissection to examine chemokine mRNA production by both retinal pigment epithelium cells and infiltrating leukocytes in inflamed eyes. Major findings included the following: 1) Three patterns of expression of the inflammation-related molecules were seen in recipients of adoptively transferred Th cells: preferential expression in Th1 recipients, or in Th2 recipients, or similar expression in both recipient groups. 2) In experimental autoimmune uveoretinitis, the inflammatory mediator expression pattern largely paralleled that seen in Th1-induced disease. 3) Both retinal pigment epithelium and infiltrating leukocytes expressed chemokine transcripts in distinct, but overlapping patterns in inflamed eyes. 4) Interestingly, transcripts of multiple cytokines, chemokines, and chemokine receptors were constitutively expressed in high levels in mouse eyes. Seven of these molecules have not been previously associated with the eye. These data underscore the multiplicity of mediators that participate in the pathogenesis of eye inflammation and point to upstream cytokines as potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859142     DOI: 10.4049/jimmunol.168.5.2483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Tolerance and autoimmunity in the eye: a role for CD8 T cells in organ-specific autoimmunity in the retina.

Authors:  John V Forrester; Richard J Cornall
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

Review 2.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

Review 3.  The role of chemokines and their receptors in uveitis.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Ghislain Opdenakker; Karel Geboes; Jo Van Damme
Journal:  Int Ophthalmol       Date:  2007-03-13       Impact factor: 2.031

Review 4.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

5.  Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells.

Authors:  Guangpu Shi; Catherine A Cox; Barbara P Vistica; Cuiyan Tan; Eric F Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis.

Authors:  Athanasios Dagkalis; Carol Wallace; Benjamin Hing; Janet Liversidge; Isabel J Crane
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

7.  Control of chemokine gradients by the retinal pigment epithelium.

Authors:  Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

8.  Type I Interferon Therapy Limits CNS Autoimmunity by Inhibiting CXCR3-Mediated Trafficking of Pathogenic Effector T Cells.

Authors:  Weiwei Wang; Wai Po Chong; Chunmei Li; Zilin Chen; Sihan Wu; Hongyan Zhou; Ying Wan; Wanjun Chen; Igal Gery; Yizhi Liu; Rachel R Caspi; Jun Chen
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

9.  Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency.

Authors:  Shao Bo Su; Rafael S Grajewski; Dror Luger; Rajeev K Agarwal; Phyllis B Silver; Jun Tang; Jingsheng Tuo; Chi-Chao Chan; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

10.  Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.

Authors:  Liem Trinh; Françoise Brignole-Baudouin; Aude Pauly; Hong Liang; Marianne Houssier; Christophe Baudouin
Journal:  Mol Vis       Date:  2008-12-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.